Neurons and nicotine addiction
Further research into nicotine and addiction highlights neurons in the brain
-
by Dave Cross
Share on:
As covered in Nature Neuroscience magazine, a team led by Olivier George, assistant professor at The Scripps Research Institute in San Diego announced the results of their research titled “VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation.” The team says they think these same neurons may be active in response to other addictive substances.
"If we can find a way to target those neurons in humans, maybe we can reduce the 'high' produced by the drug and reduce the withdrawal symptoms."
Olivier George.
The team hold out hopes that their findings will lead to the development of drugs or gene therapies that can target the neurons and aid in addiction quit attempts.
Previously, the region of the brain they were looking at had only been associated with the pleasure/reward aspect of addiction and not the stress/withdrawal system. Further investigation was triggered when Olivier discovered a protein in that region strongly associated with anxiety and depression.
Using radioactive markers, the team observed the region in rat brain samples and eventually discovered the tell tale black dots on X-ray scans in the ventral tegmental area (VTA) - an area of the brain where the neurons are found.
"If you look in a textbook, these neurons don't exist in the VTA. That was the most exciting day of my career."
Olivier George.
The research was expanded to cover mice and rat brains. The rodents had been developed to have nicotine dependence similar to a human using 40 cigarettes per day.
“Results revealed that the neurons in the VTA were activated during withdrawal, and upon examining brain samples from humans, the team found that these same VTA neurons are present.”
Results from previous studies into rodent and human failed quit attempts have shown that both will return to consuming more nicotine than used originally. Researchers looked to see if this was linked to the neuron activity in this region of the brain.
The team found that rodents with fewer of these neurons did not increase their nicotine uptake.
"That changes the whole conceptual framework. We have to look at everything again, going back to the 1970s. It's possible that when you activate those neurons, you have the reward system that's activated - you have this euphoria, this high - but at the same time you activate this stress peptide."
Olivier George.
Dave Cross
Journalist at POTVDave is a freelance writer; with articles on music, motorbikes, football, pop-science, vaping and tobacco harm reduction in Sounds, Melody Maker, UBG, AWoL, Bike, When Saturday Comes, Vape News Magazine, and syndicated across the Johnston Press group. He was published in an anthology of “Greatest Football Writing”, but still believes this was a mistake. Dave contributes sketches to comedy shows and used to co-host a radio sketch show. He’s worked with numerous start-ups to develop content for their websites.
Join the discussion
Harm Reduction For The Rich
The United Kingdom risks becoming a harm reduction country only for the wealthy, according to Michael Landl of the World Vapers’ Alliance
-
by Dave Cross
Longfills as an Alternative to Disposables
The disposable vape ban will impact many people, but there’s no reason to be concerned… Grab yourself a pod kit and a Longfill and you’ll be back to vaping the way you want to, just in a cheaper, more environmentally friendly and legal way.
COP10 is a Threat to Safer Nicotine Products
The EU obscures its position on low-risk alternatives to smoking before the WHO COP10 conference in Panama, starting Monday
-
by Dave Cross
Nicotine Is Not A Culprit
Planet of the Vapes has always encouraged smokers to use the quit product that works best for them, and snus is a product that seems to be unfairly blocked because it contains nicotine
-
by Dave Cross
